至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Enhancer of polycomb1 lessens neointima formation by potentiation of myocardin-induced smooth muscle differentiation.

Atherosclerosis.. 2012-05;  222(1):84-91
Joung H, Kwon JS, Kim JR, Shin S, Kang W, Ahn Y, Kook H, Kee HJ. a Department of Pharmacology and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Republic of Koreab Heart Research Center of Chonnam National University Hospital, Gwangju 501-757, Republic of Koreac Department of Cellular and Integrative Physiology, University School of Medicine, Indianapolis, IN, USA
Products/Services Used Details Operation

摘要

ObjectivePreviously, we reported that enhancer of polycomb1 (Epc1) induces skeletal muscle differentiation through the serum response factor (SRF). Considering that SRF plays a critical role in vascular smooth muscle cell (VSMC) differentiation, we expected that Epc1 also works in VSMCs. Here we examined the effect of Epc1 on neointima formation after arterial balloon injury and the underlying mechanism.MethodsEpc1 expression was examined in carotid artery injury or VSMC models. Interaction with myocardin (Myocd), a master regulator of smooth muscle differentiation, was examined by immunoprecipitation or promoter analysis with smooth muscle (SM) 22α promoter. Finally, we investigated whether local deliver... More

关键词

Enhancer of polycomb1 (Epc1); Serum response factor (SRF); Myocardin (Myocd); Vascular smooth muscle cell differentiation; Neointimal formation